Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011623901> ?p ?o ?g. }
- W2011623901 endingPage "e100909" @default.
- W2011623901 startingPage "e100909" @default.
- W2011623901 abstract "Objectives Septic syndromes are the leading cause of death in intensive care units. They are characterized by the development of immune dysfunctions such as endotoxin tolerance (ET), whose intensity and duration are associated with increased risk of nosocomial infections and mortality. Alarmins S100A8 and S100A9 have been shown to be increased after septic shock. Importantly, a delayed S100A9 mRNA increase predicts hospital-acquired infection in patients. The aim of this study was to investigate the regulation of S100A8 and S100A9 mRNA expression in an ex vivo model of ET. Subjects and Measurements ET was reproduced ex vivo by priming healthy peripheral blood mononuclear cells (number of donors = 9 to 10) with low-dose endotoxin (2 ng/ml) before stimulation with high dose endotoxin (100 ng/ml). S100A8 and S100A9 mRNA levels were measured by quantitative real-time polymerase chain reactions. Main Results ET was established by observing decreased TNFα and increased IL-10 transcriptomic responses to two subsequent endotoxin challenges. Interestingly, ET was associated with increased S100A8 and S100A9 mRNA expression ex vivo. We showed that IL-10 played a role in this process, since S100A8 and S100A9 mRNA increases were significantly abrogated by IL-10 blockade in the model. Conversely, treatment with rIFN-γ, a pro-inflammatory and immunostimulating molecule known to block ET induction, was able to restore normal S100A8 and S100A9 mRNA in this model. Conclusions In this ex vivo model, we observed that S100A8 and S100A9 mRNA expression was significantly increased during ET. This reproduced ex vivo the observations we had previously made in septic shock patients. Interestingly, IL-10 blockade and rIFN-γ treatment partially abrogated S100A8/A9 mRNA increases in this model. Pending confirmation in larger, independent clinical studies, these preliminary results suggest that S100A8 and S100A9 mRNA levels might be used as surrogate markers of ET and as stratification tools for personalized immunotherapy in septic shock patients." @default.
- W2011623901 created "2016-06-24" @default.
- W2011623901 creator A5004262919 @default.
- W2011623901 creator A5017313235 @default.
- W2011623901 creator A5027065388 @default.
- W2011623901 creator A5058688162 @default.
- W2011623901 creator A5067160216 @default.
- W2011623901 creator A5072497906 @default.
- W2011623901 creator A5082678142 @default.
- W2011623901 creator A5082784886 @default.
- W2011623901 creator A5083086451 @default.
- W2011623901 date "2014-06-23" @default.
- W2011623901 modified "2023-10-18" @default.
- W2011623901 title "S100A8/A9 mRNA Induction in an Ex Vivo Model of Endotoxin Tolerance: Roles of IL-10 and IFNγ" @default.
- W2011623901 cites W1544335514 @default.
- W2011623901 cites W1566992315 @default.
- W2011623901 cites W1567450894 @default.
- W2011623901 cites W1617901512 @default.
- W2011623901 cites W1645308222 @default.
- W2011623901 cites W1834782762 @default.
- W2011623901 cites W1925993589 @default.
- W2011623901 cites W1950981769 @default.
- W2011623901 cites W1964234893 @default.
- W2011623901 cites W1964649844 @default.
- W2011623901 cites W1966814333 @default.
- W2011623901 cites W1967478542 @default.
- W2011623901 cites W1970766316 @default.
- W2011623901 cites W1972757665 @default.
- W2011623901 cites W1972935488 @default.
- W2011623901 cites W1990852282 @default.
- W2011623901 cites W1993525981 @default.
- W2011623901 cites W1996313175 @default.
- W2011623901 cites W2005948700 @default.
- W2011623901 cites W2012526179 @default.
- W2011623901 cites W2019560197 @default.
- W2011623901 cites W2026359714 @default.
- W2011623901 cites W2039091926 @default.
- W2011623901 cites W2046013120 @default.
- W2011623901 cites W2056411965 @default.
- W2011623901 cites W2057529688 @default.
- W2011623901 cites W2064854957 @default.
- W2011623901 cites W2070156256 @default.
- W2011623901 cites W2072013779 @default.
- W2011623901 cites W2074571330 @default.
- W2011623901 cites W2085341927 @default.
- W2011623901 cites W2097476575 @default.
- W2011623901 cites W2097599737 @default.
- W2011623901 cites W2098627309 @default.
- W2011623901 cites W2099599731 @default.
- W2011623901 cites W2101831679 @default.
- W2011623901 cites W2110068780 @default.
- W2011623901 cites W2115623818 @default.
- W2011623901 cites W2117979840 @default.
- W2011623901 cites W2121171067 @default.
- W2011623901 cites W2130740394 @default.
- W2011623901 cites W2133955925 @default.
- W2011623901 cites W2135393201 @default.
- W2011623901 cites W2135577920 @default.
- W2011623901 cites W2138372479 @default.
- W2011623901 cites W2140816250 @default.
- W2011623901 cites W2152676422 @default.
- W2011623901 cites W2168456558 @default.
- W2011623901 cites W2319809815 @default.
- W2011623901 cites W4321258480 @default.
- W2011623901 doi "https://doi.org/10.1371/journal.pone.0100909" @default.
- W2011623901 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4067416" @default.
- W2011623901 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24956170" @default.
- W2011623901 hasPublicationYear "2014" @default.
- W2011623901 type Work @default.
- W2011623901 sameAs 2011623901 @default.
- W2011623901 citedByCount "29" @default.
- W2011623901 countsByYear W20116239012015 @default.
- W2011623901 countsByYear W20116239012016 @default.
- W2011623901 countsByYear W20116239012017 @default.
- W2011623901 countsByYear W20116239012018 @default.
- W2011623901 countsByYear W20116239012019 @default.
- W2011623901 countsByYear W20116239012020 @default.
- W2011623901 countsByYear W20116239012021 @default.
- W2011623901 countsByYear W20116239012022 @default.
- W2011623901 countsByYear W20116239012023 @default.
- W2011623901 crossrefType "journal-article" @default.
- W2011623901 hasAuthorship W2011623901A5004262919 @default.
- W2011623901 hasAuthorship W2011623901A5017313235 @default.
- W2011623901 hasAuthorship W2011623901A5027065388 @default.
- W2011623901 hasAuthorship W2011623901A5058688162 @default.
- W2011623901 hasAuthorship W2011623901A5067160216 @default.
- W2011623901 hasAuthorship W2011623901A5072497906 @default.
- W2011623901 hasAuthorship W2011623901A5082678142 @default.
- W2011623901 hasAuthorship W2011623901A5082784886 @default.
- W2011623901 hasAuthorship W2011623901A5083086451 @default.
- W2011623901 hasBestOaLocation W20116239011 @default.
- W2011623901 hasConcept C104317684 @default.
- W2011623901 hasConcept C105580179 @default.
- W2011623901 hasConcept C137061746 @default.
- W2011623901 hasConcept C150194340 @default.
- W2011623901 hasConcept C150903083 @default.
- W2011623901 hasConcept C162317418 @default.
- W2011623901 hasConcept C202751555 @default.